JAMP Pharma

Focus: JAMP Pharma is a generic pharmaceutical manufacturer headquartered in Quebec with 201-500 employees, focused on bringing affordable medications to market across multiple therapeutic areas including immunology.

Immunology

Profile data last refreshed 6h ago · AI intelligence enriched 2mo ago

Funding Stage

PUBLIC

Employees

201-500

Open Jobs

About JAMP Pharma

AI assessmentNot Hiring

No open roles listed right now. Follow JAMP Pharma to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

3/9 — Basic

Company HealthSolid

Pipeline

Early-stage

1 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

AVT02

Crohn Disease

N/A

Clinical Trials (1)

NCT05913817The Evaluation of Injection Site Pain and Adherence in Patients Switching From a Low To High Concentration Adalimumab (AVT-02) Across Multiple Indications.

N/A

Help build intelligence for JAMP Pharma

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Established 35-year-old company with stable public company backing provides employment security in a mature generics business
Immunology specialization offers focus in a high-value therapeutic area despite generics-heavy portfolio
Mid-sized organization (201-500 employees) offers visibility and cross-functional exposure without enterprise bureaucracy

Watch Out For

Zero active job openings signals no current hiring momentum or potential organizational contraction
Minimal pipeline activity (1 trial total, no phase progression data) indicates limited R&D investment or innovation trajectory
Generic drug business model typically offers lower margins and less career prestige than specialty or branded pharmaceuticals

Generated by Claude from JAMP Pharma's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.